Guided Therapeutics (GTHP) EPS (Basic) (2010 - 2025)
Guided Therapeutics (GTHP) reported EPS (Basic) of -$0.02 for Q4 2025, down 24.94% on a YoY basis from -$0.02 in Q4 2024, and down 58.72% sequentially from -$0.01 in Q3 2025.
Guided Therapeutics (GTHP) EPS (Basic) (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of EPS (Basic) data on file, last reported at -$0.02 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) fell 24.94% year-over-year to -$0.02; the trailing twelve-month figure through Dec 2025 stood at -$0.04 (up 6.87% YoY), and the FY2025 full-year result was -$0.04, up 6.87% from the prior year.
- EPS (Basic) slipped to -$0.02 in Q4 2025, from -$0.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q3 2021 to a low of -$43.43 in Q1 2021.
- A 5-year average of -$2.6 and a median of -$0.02 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 99.98% in 2021 and tumbled 40878.04% in 2024, its largest moves.
- Tracing GTHP's EPS (Basic) over 5 years: stood at -$0.04 in 2021, then slumped by 50.14% to -$0.06 in 2022, then jumped by 83.94% to -$0.01 in 2023, then slumped by 33.09% to -$0.01 in 2024, then slipped by 24.94% to -$0.02 in 2025.
- Business Quant data shows GTHP's EPS (Basic) at -$0.02 in Q4 2025, -$0.01 in Q3 2025, and -$0.01 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -8.05 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.04 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -0.09 |
| Mar 31, 2021 | -43.43 |